Able Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$160K Sell
14,315
-6,867
-32% -$83.5K 0.04% 162
2026
Q1
$296K Sell
21,182
-13,691
-39% -$192K 0.08% 97
2025
Q4
$502K Sell
34,873
-7,763
-18% -$117K 0.16% 72
2025
Q3
$679K Buy
42,636
+15,872
+59% +$261K 0.26% 60
2025
Q2
$474K Buy
+26,764
New +$521K 0.24% 65

Other funds holding BTAL

Able Wealth Management's BTAL Position: Q2 2026 in Review

Able Wealth Management reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 32% in Q2 2026, selling an estimated $83.5K and leaving 14,315 shares worth $160K. The position accounts for 0.04% of the portfolio, ranked #162.

Able Wealth Management first reported a position in BTAL in Q2 2025 and has held it in 5 quarters since. The position peaked at $679K in Q3 2025. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Able Wealth Management held 14,315 shares of AGF US Market Neutral Anti-Beta Fund worth $160K as of Q2 2026.
  • Able Wealth Management sold 6,867 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $83.5K.
  • AGF US Market Neutral Anti-Beta Fund made up 0.04% of Able Wealth Management's portfolio in Q2 2026, its #162 holding.
  • Able Wealth Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2025 and has held it in 5 quarters since.
  • Able Wealth Management's AGF US Market Neutral Anti-Beta Fund position peaked at $679K in Q3 2025.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Able Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.